Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Terminated1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT04309084Phase 1Unknown
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
AnalgesicsAnalgesics, Non-NarcoticAntineoplastic Agents+17 more
StudydirectorStart date: 2020-05-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05207722Phase 1/2StudyDirector

CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

Metastatic HER2 Positive Gastroesophageal Junction Cancer
Terminated
NCT04309084Phase 1StudyDirector

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

AnalgesicsAnalgesics, Non-NarcoticAntineoplastic Agents+17 more
Unknown

All 2 trials loaded